Associations of preoperative anemia and postoperative hemoglobin values with hospital costs in total knee arthroplasty (TKA).


Journal

Archives of orthopaedic and trauma surgery
ISSN: 1434-3916
Titre abrégé: Arch Orthop Trauma Surg
Pays: Germany
ID NLM: 9011043

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 27 02 2023
accepted: 22 05 2023
medline: 5 10 2023
pubmed: 12 6 2023
entrez: 12 6 2023
Statut: ppublish

Résumé

Total knee arthroplasty are among the most frequently conducted surgeries, due to an aging society. Since hospital costs are subsequently rising, adequate preparation of patients and reimbursement becomes more and more important. Recent literature revealed anemia as a risk factor for enhanced length of stay (LOS) and complications. This study analyzed whether preoperative hemoglobin (Hb) and postoperative Hb were associated with total hospital costs and general ward costs. The study comprised 367 patients from a single high-volume hospital in Germany. Hospital costs were calculated with standardized cost accounting methods. Generalized linear models were applied to account for confounders, such as age, comorbidities, body mass index, insurance status, health-related quality of life, implant types, incision-suture-time and tranexamic acid. Preoperative anemic women had 426 Euros higher general ward costs (p < 0.01), due to increased LOS. For men, 1 g/dl less Hb loss between the preoperative value and the value before discharge reduced total costs by 292 Euros (p < 0.001) and 161 Euros fewer general ward costs (p < 0.001). Total hospital costs were reduced by 144 Euros with 1 g/dl higher Hb on day 2 postoperatively for women (p < 0.01). Preoperative anemia was associated with increased general ward costs for women and Hb loss with decreasing total hospital costs for men and women. Cost containment, especially reduced utilization of the general ward, may be feasible with the correction of anemia for women. Postoperative Hb values may be a factor for adjustments of reimbursement systems. Retrospective cohort study, III.

Sections du résumé

BACKGROUND BACKGROUND
Total knee arthroplasty are among the most frequently conducted surgeries, due to an aging society. Since hospital costs are subsequently rising, adequate preparation of patients and reimbursement becomes more and more important. Recent literature revealed anemia as a risk factor for enhanced length of stay (LOS) and complications. This study analyzed whether preoperative hemoglobin (Hb) and postoperative Hb were associated with total hospital costs and general ward costs.
METHODS METHODS
The study comprised 367 patients from a single high-volume hospital in Germany. Hospital costs were calculated with standardized cost accounting methods. Generalized linear models were applied to account for confounders, such as age, comorbidities, body mass index, insurance status, health-related quality of life, implant types, incision-suture-time and tranexamic acid.
RESULTS RESULTS
Preoperative anemic women had 426 Euros higher general ward costs (p < 0.01), due to increased LOS. For men, 1 g/dl less Hb loss between the preoperative value and the value before discharge reduced total costs by 292 Euros (p < 0.001) and 161 Euros fewer general ward costs (p < 0.001). Total hospital costs were reduced by 144 Euros with 1 g/dl higher Hb on day 2 postoperatively for women (p < 0.01).
CONCLUSION CONCLUSIONS
Preoperative anemia was associated with increased general ward costs for women and Hb loss with decreasing total hospital costs for men and women. Cost containment, especially reduced utilization of the general ward, may be feasible with the correction of anemia for women. Postoperative Hb values may be a factor for adjustments of reimbursement systems.
LEVEL OF EVIDENCE METHODS
Retrospective cohort study, III.

Identifiants

pubmed: 37306776
doi: 10.1007/s00402-023-04929-4
pii: 10.1007/s00402-023-04929-4
pmc: PMC10258736
doi:

Substances chimiques

Hemoglobins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6741-6751

Subventions

Organisme : German Federal Ministry of Education and Research
ID : 01GY1603A

Informations de copyright

© 2023. The Author(s).

Références

J Knee Surg. 2019 Aug;32(8):730-735
pubmed: 30921822
Health Econ Rev. 2012 Aug 30;2(1):15
pubmed: 22935314
Health Econ. 2008 Jan;17(1 Suppl):S9-20
pubmed: 18186038
BMC Musculoskelet Disord. 2021 Sep 12;22(1):776
pubmed: 34511099
J Arthroplasty. 2020 Sep;35(9):2363-2366
pubmed: 32451280
Hip Pelvis. 2021 Sep;33(3):140-146
pubmed: 34552891
Int Orthop. 2015 Jul;39(7):1307-14
pubmed: 25711395
Medicine (Baltimore). 2021 Sep 3;100(35):e27097
pubmed: 34477145
J Arthroplasty. 2018 Oct;33(10):3090-3098.e1
pubmed: 29805106
J Arthroplasty. 2021 Jul;36(7):2281-2289
pubmed: 33549420
J Arthroplasty. 2020 Nov;35(11):3084-3088
pubmed: 32654943
Acta Orthop. 2021 Feb;92(1):29-35
pubmed: 33106101
Orthopedics. 2022 Mar-Apr;45(2):e86-e90
pubmed: 34978512
J Arthroplasty. 2020 Oct;35(10):3057-3058
pubmed: 32564966
Orthop Surg. 2018 Feb;10(1):8-16
pubmed: 29424017
Acta Orthop Belg. 2021 Mar;87(1):9-16
pubmed: 34129752
J Arthroplasty. 2022 Apr;37(4):721-726
pubmed: 34998908
Health Econ. 2011 Aug;20(8):897-916
pubmed: 20799344
J Arthroplasty. 2018 Sep;33(9):2728-2733.e3
pubmed: 29793850
Knee Surg Sports Traumatol Arthrosc. 2022 Oct;30(10):3304-3310
pubmed: 35211774
J Arthroplasty. 2022 Jun;37(6S):S155-S158
pubmed: 35202759
J Orthop Traumatol. 2015 Sep;16(3):209-13
pubmed: 25697846
J Arthroplasty. 2021 Mar;36(3):1023-1028
pubmed: 33067093
Bone Joint J. 2019 Jul;101-B(7_Supple_C):64-69
pubmed: 31256638
J Arthroplasty. 2020 May;35(5):1252-1256
pubmed: 32029350
Health Policy. 1996 Jul;37(1):53-72
pubmed: 10158943
Curr Rev Musculoskelet Med. 2017 Sep;10(3):370-377
pubmed: 28741101
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Orthop Surg Res. 2021 Sep 26;16(1):572
pubmed: 34565418
Osteoarthritis Cartilage. 2020 Mar;28(3):242-248
pubmed: 31945457
Med Care. 1998 Jan;36(1):8-27
pubmed: 9431328

Auteurs

Caroline Schatz (C)

Ludwig-Maximilians-Universität München, LMU Munich School of Management, Institute for Health Economics and Health Care Management, Ludwigstr. 28, 80539, Munich, Germany. schatz@lmu.de.
Helmholtz Zentrum München, Institute for Health Economics and Health Care Management, Munich, Germany. schatz@lmu.de.
Environmental Health Center at Helmholtz Munich, Munich, Germany. schatz@lmu.de.

Werner Plötz (W)

Krankenhaus Barmherzige Brüder München, Akademisches Lehrkrankenhaus der Technischen Universität München, Munich, Germany.
Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
Orthopaedic Praxis Munich-Nymphenburg, Munich, Germany.

Johannes Beckmann (J)

Krankenhaus Barmherzige Brüder München, Akademisches Lehrkrankenhaus der Technischen Universität München, Munich, Germany.

Katharina Bredow (K)

Helmholtz Zentrum München, Institute for Health Economics and Health Care Management, Munich, Germany.

Reiner Leidl (R)

Ludwig-Maximilians-Universität München, LMU Munich School of Management, Institute for Health Economics and Health Care Management, Ludwigstr. 28, 80539, Munich, Germany.
Helmholtz Zentrum München, Institute for Health Economics and Health Care Management, Munich, Germany.

Peter Buschner (P)

Krankenhaus Barmherzige Brüder München, Akademisches Lehrkrankenhaus der Technischen Universität München, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH